Jae Ho Jeong

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study

Changhoon Yoo, Kyu‐pyo Kim, Jae Ho Jeong et al. · The Lancet Oncology · 2021 · 220 citations

Medicine, Oncology, Pharmacology +14

Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis

JiHoon Kang, Inhwan Hwang, Changhoon Yoo et al. · Investigational New Drugs · 2018 · 147 citations

Medicine, Oncology, Pharmacology +13

New Design and Identification of the Medial Sural Perforator Flap: An Anatomical Study and Its Clinical Applications

Hyo Heon Kim, Jae Ho Jeong, Jung Hyun Seul et al. · Plastic & Reconstructive Surgery · 2006 · 100 citations

Medicine, Anatomy, Surgery +16

Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker

Heejung Chae, Deokhoon Kim, Changhoon Yoo et al. · European Journal of Cancer · 2019 · 95 citations

Medicine, Molecular Genetics, Oncology +17

Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients

Seung Hee Seo, Sung-Eun Kim, Yoon‐Koo Kang et al. · BMC Cancer · 2016 · 94 citations · Full text

Agriculture, Nutrition, Oncology +17